Did you know that pets, like humans, can get cancer?

This biotech company, Protect Biotech (also known as Protect Animal Health Inc), is developing cancer immunotherapy for animals, including a broad-spectrum PD-L1/CTLA-4 vaccine for dogs, aiming to tap into the USD$1.53 billion companion animal market!

According to the National Canine Cancer Foundation (NCCF), 1 in 3 dogs will develop tumors. While Taiwan's veterinary industry has traditionally focused on livestock medicine, Protect Biotech is pioneering advanced pet cancer treatments, introducing a new business model for pet medicine and expanding into the global market.

Haolin Sung, CEO of Protect Biotech, highlighted that many pet owners were unaware that animals could develop cancer. He envisions Protect Biotech as Taiwan's incubator for veterinary medicine, adapting human therapeutics for pets to create innovative and effective treatments.

Read more: http://bit.ly/v118cover3

Follow Globalbio for more biotech updates!